Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To assess the effects of CAD106 and CNP520, respectively, vs. placebo on Time-to-event, with event defined as a diagnosis of MCI due to AD or dementia due to AD, whichever occurs first during the course of the study. - To assess the effects of CAD106 and CNP520, respectively, vs. placebo on cognition as measured by the change from Baseline to Month 60 in the APCC test score.
Critère d'inclusion
- Alzheimer's disease